- Home
- OCX vs TPCS Comparison
OCX vs TPCS Comparison
Compare OCX & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- TPCS
- Stock Information
- Founded
- OCX 2009
- TPCS 1956
- Country
- OCX United States
- TPCS United States
- Employees
- OCX N/A
- TPCS N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TPCS Metal Fabrications
- Sector
- OCX Health Care
- TPCS Industrials
- Exchange
- OCX Nasdaq
- TPCS Nasdaq
- Market Cap
- OCX 38.7M
- TPCS 32.1M
- IPO Year
- OCX N/A
- TPCS N/A
- Fundamental
- Price
- OCX $2.61
- TPCS $3.10
- Analyst Decision
- OCX Buy
- TPCS
- Analyst Count
- OCX 3
- TPCS 0
- Target Price
- OCX $4.42
- TPCS N/A
- AVG Volume (30 Days)
- OCX 64.0K
- TPCS 20.3K
- Earning Date
- OCX 11-12-2024
- TPCS 11-12-2024
- Dividend Yield
- OCX N/A
- TPCS N/A
- EPS Growth
- OCX N/A
- TPCS N/A
- EPS
- OCX N/A
- TPCS N/A
- Revenue
- OCX $709,000.00
- TPCS $32,205,714.00
- Revenue This Year
- OCX N/A
- TPCS N/A
- Revenue Next Year
- OCX $167.93
- TPCS N/A
- P/E Ratio
- OCX N/A
- TPCS N/A
- Revenue Growth
- OCX N/A
- TPCS 1.51
- 52 Week Low
- OCX $2.29
- TPCS $2.85
- 52 Week High
- OCX $4.34
- TPCS $7.15
- Technical
- Relative Strength Index (RSI)
- OCX 30.23
- TPCS 36.61
- Support Level
- OCX $2.73
- TPCS $2.95
- Resistance Level
- OCX $3.04
- TPCS $3.49
- Average True Range (ATR)
- OCX 0.14
- TPCS 0.24
- MACD
- OCX -0.03
- TPCS -0.04
- Stochastic Oscillator
- OCX 0.00
- TPCS 15.15
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.